Stock BHC BAUSCH HEALTH COMPANIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Bausch Health Companies Inc.

Equities

BHC

CA0717341071

Market Closed - Nyse
Other stock markets
 01:30:01 27/04/2024 am IST 		5-day change 1st Jan Change
8.71 USD +1.04% Intraday chart for Bausch Health Companies Inc. +0.23% +8.60%
25/04 Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes MT
25/04 Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bausch + Lomb Reports "Statistically Significant" Results From Study of Nutritional Supplement for Dry Eyes
MT
Bausch + Lomb Brief: Announcing "Statistically Significant" Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
MT
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
MT
RBC Previews Bausch Health's Q1, Trims Target to US$11
MT
RBC Trims Price Target on Bausch Health to $11 From $12, Keeps Sector Perform Rating
MT
RBC Cuts Bausch + Lomb Target to US$18, Reiterates Outperform, as Previews Q1
MT
Bausch Health's Issuer Credit Rating Upgraded by S&P
MT
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says
MT
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds
MT
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan
AQ
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
AQ
Bausch Health to Announce First-Quarter 2024 Results on May 2
AQ
Bausch wins US appeal to block Alvogen generic of diarrhea drug
RE
Canadian Investment Regulatory Organization Trade Resumption - BHC
AQ
Canadian Investment Regulatory Organization Trading Halt - BHC
AQ
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
CI
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
RE
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals
MT
North American Morning Briefing : Inflation Data, -2-
DJ
Trump eyes $43 million haul from biggest fundraiser yet
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BHC Stock
  4. News Bausch Health Companies Inc.